Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼

0 252

Cited 0 times in

DC Field	Value	Language
dc.date.accessioned	2023-06-02T00:39:47Z	-
dc.date.available	2023-06-02T00:39:47Z	-
dc.date.issued	2022-09	-
dc.identifier.issn	0923-7534	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/194337	-
dc.description.statementOfResponsibility	restriction	-
dc.language	English	-
dc.publisher	Oxford University Press	-
dc.relation.isPartOf	ANNALS OF ONCOLOGY	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Dept. of Internal Medicine (내과학교실)	-
dc.contributor.googleauthor	J.H. Kim	-
dc.contributor.googleauthor	Y. Kook	-
dc.contributor.googleauthor	J.S. Jang	-
dc.contributor.googleauthor	S.J. Bae	-
dc.contributor.googleauthor	B.J. Chae	-
dc.contributor.googleauthor	D. Shin	-
dc.contributor.googleauthor	J.M. Ryu	-
dc.contributor.googleauthor	J. Sohn	-
dc.contributor.googleauthor	J. Jeong	-
dc.contributor.googleauthor	S.G. Ahn	-
dc.identifier.doi	10.1016/j.annonc.2022.07.201	-
dc.relation.journalcode	J00171	-
dc.identifier.eissn	1569-8041	-
dc.identifier.url	https://www.sciencedirect.com/science/article/pii/S092375342202052X	-
dc.citation.volume	33	-
dc.citation.number	Suppl 7	-
dc.citation.startPage	S614	-
dc.identifier.bibliographicCitation	ANNALS OF ONCOLOGY, Vol.33(Suppl 7) : S614, 2022-09	-

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

Show simple item record Find it @ YMLIB

YUHSpace: Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼